Skip to content

Drug interactions

Erdafitinib + Memantine-donepezil

Severity: Moderate

Erdafitinib and Memantine-donepezil: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib is an OCT2 substrate and memantine is cleared partly by renal tubular secretion involving OCT2-type transport. Competition could raise erdafitinib exposure, but the evidence is limited.

What this interaction means in plain words

Erdafitinib and Memantine-donepezil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erdafitinib belongs to Oncology; Memantine-donepezil belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible competition for renal OCT2-mediated tubular secretion reduces erdafitinib clearance.

What to do

Monitor for erdafitinib adverse effects such as hyperphosphatemia, ocular and skin toxicity, and reduce the dose based on tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Memantine-donepezil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Memantine-donepezil?

MediHelp rates the interaction as moderate. Erdafitinib and Memantine-donepezil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib is an OCT2 substrate and memantine is cleared partly by renal tubular secretion involving OCT2-type transport. Competition could raise erdafitinib exposure, but the evidence is limited.

How serious is the interaction between Erdafitinib and Memantine-donepezil?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for erdafitinib adverse effects such as hyperphosphatemia, ocular and skin toxicity, and reduce the dose based on tolerability.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in